2013

Evaluation of histological damage of solid organs after donor preconditioning with thymoglobulin in an experimental rat model

F. Cicora,P. Stringa,D. Guerrieri,D. Vásquez,F. Toniolo,J. Roberti and C. Raimondi. Evaluation of histological damage of solid organs after donor preconditioning with thymoglobulin in an experimental rat model. Transpl Immunol. 2013;28(4):10.1016/j.trim.2013.04.002.

Evaluation of histological damage of solid organs after donor preconditioning with thymoglobulin in an experimental rat model Ver más »

Estándares Consolidados de Reporte de Evaluaciones Económicas Sanitarias: Versión en Español de la Lista de Comprobación CHEERS

F. Augustovski,S. García Martí and A. Pichon-Riviere. Estándares Consolidados de Reporte de Evaluaciones Económicas Sanitarias: Versión en Español de la Lista de Comprobación CHEERS. Value Health Reg Issues. 2013;2(3):10.1016/j.vhri.2013.10.004.

Estándares Consolidados de Reporte de Evaluaciones Económicas Sanitarias: Versión en Español de la Lista de Comprobación CHEERS Ver más »

Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis-C Virus Infection in Venezuela

S. G. Marti,A. Alcaraz,P. Valanzasca,O. U. Garay,M. McMullen,L. R. Ares,C. A. Obando and J. Caporale. COST-EFFECTIVENESS OF TELAPREVIR IN GENOTYPE 1 CHRONIC HEPATITIS-C VIRUS INFECTION IN VENEZUELA. Value in Health. 2013;16(7).

Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis-C Virus Infection in Venezuela Ver más »

Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in Chile

S. G. Marti,A. Alcaraz,P. Valanzasca,U. G. Ulises,M. McMullen,L. R. Ares,I. Peirano,D. O. Reisberg,A. S. Ried,J. Poniachik,J. R. B. Barril and J. Caporale. COST-EFFECTIVENESS OF TELAPREVIR IN GENOTYPE 1 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION IN CHILE. Value in Health. 2013;16(7).

Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in Chile Ver más »

Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in Colombia

S. G. Marti,A. Alcaraz,P. Valanzasca,O. U. Garay,M. McMullen,L. R. Ares,V. Idrovo,J. P. Ortiz,M. Tapias,J. Obregon,J. G. Ariza and J. Caporale. COST-EFFECTIVENESS OF TELAPREVIR IN GENOTYPE 1 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION IN COLOMBIA. Value in Health. 2013;16(7).

Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in Colombia Ver más »

Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in Argentina

S. G. Marti,A. Alcaraz,P. Valanzasca,U. G. Ulises,M. McMullen,L. R. Ares,I. Peirano,F. Bessone,H. Fainboim,A. Gadano,O. Galdame,C. Vujacich and J. Caporale. COST-EFFECTIVENESS OF TELAPREVIR IN GENOTYPE 1 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION IN ARGENTINA. Value in Health. 2013;16(7).

Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in Argentina Ver más »

Consolidated Health Economic Evaluation Reporting Standards (CHEERS)-Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force

D. Husereau,M. Drummond,S. Petrou,C. Carswell,D. Moher,D. Greenberg,F. Augustovski,A. H. Briggs,J. Mauskopf,E. Loder and I. H. E. E. Publica. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)-Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value in Health. 2013;16(2):10.1016/j.jval.2013.02.002.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS)-Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force Ver más »

Common genetic variants in the endothelial system predict blood pressure response to sodium intake: the GenSalt study

M. D. Defagó,D. Gu,J. E. Hixson,L. C. Shimmin,T. K. Rice,C. C. Gu,C. E. Jaquish,D. P. Liu,J. He and T. N. Kelly. Common genetic variants in the endothelial system predict blood pressure response to sodium intake: the GenSalt study. Am J Hypertens. 2013;26(5):10.1093/ajh/hps099.

Common genetic variants in the endothelial system predict blood pressure response to sodium intake: the GenSalt study Ver más »

Clinical experience with thymoglobulin and antithymocyte globulin-Fresenius as induction therapy in renal transplant patients: a retrospective study

F. Cicora,F. Mos,M. Paz and J. Roberti. Clinical experience with thymoglobulin and antithymocyte globulin-Fresenius as induction therapy in renal transplant patients: a retrospective study. Exp Clin Transplant. 2013;11(5):10.6002/ect.2013.0027.

Clinical experience with thymoglobulin and antithymocyte globulin-Fresenius as induction therapy in renal transplant patients: a retrospective study Ver más »

CALIBRATION OF A COST-EFFECTIVENESS MODEL TO EVALUATE THE INCORPORATION OF A QUADRIVALENT HPV TYPES 6, 11, 16, 18 VACCINE IN ARGENTINA: DISEASE BURDEN COMPONENT

A. Pichon-Riviere,J. Caporale,A. Alcaraz,A. Bardach,K. Klein,L. R. Ares and F. Augustovski. CALIBRATION OF A COST-EFFECTIVENESS MODEL TO EVALUATE THE INCORPORATION OF A QUADRIVALENT HPV TYPES 6, 11, 16, 18 VACCINE IN ARGENTINA: DISEASE BURDEN COMPONENT. Value in Health. 2013;16(7):10.1016/j.jval.2013.08.2126.

CALIBRATION OF A COST-EFFECTIVENESS MODEL TO EVALUATE THE INCORPORATION OF A QUADRIVALENT HPV TYPES 6, 11, 16, 18 VACCINE IN ARGENTINA: DISEASE BURDEN COMPONENT Ver más »